Skip to content

Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis

Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03259659
Enrollment
20
Registered
2017-08-24
Start date
2017-11-30
Completion date
2020-02-29
Last updated
2020-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

1. To prove that patients with ulcerative proctitis and proctosigmoiditis have impaired autonomic functions, i.e. increased sympathetic activity and/or reduced vagal tone. 2. To demonstrate inflammatory cytokine imbalance, i.e., increased pro-inflammatory cytokines. Presence of these abnormalities would make patients with ulcerative proctitis and proctosigmoiditis good candidates for future sacral nerve stimulation therapy.

Interventions

OTHERECG recording, inflammatory cytokines, microbiota, ulcerative colitis disease activity index

In this study, an electrocardiogram signal will be recorded for 30 min in the fasting state, and blood samples for inflammatory cytokines analysis (7 ml) will be taken at the end of the ECG recording; fecal samples will be taken on the experimental day before the study. In addition, ulcerative colitis disease activity index will be assessed using the Mayo scoring system.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* No any systemic diseases; * no proctitis or proctosigmoiditis; * no history of gastrointestinal surgery; * no symptoms of diarrhea or fecal urgency during the past 2 weeks; * not taking any medications except contraceptives during the past 2 weeks; * age 18-65.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
symptoms characteristics in ulcerative colitis patients1 dayulcerative colitis disease activity index will be assessed using the Mayo scoring system, which includes stool frequency, rectal bleeding, mucosal appearance at endoscopy and physician rating of disease activity. The patient will get a score from 0 to 20, with higher score indicating more severe disease.

Secondary

MeasureTime frameDescription
autonomic profile characteristics in ulcerative colitis patients and healthy controls1 dayheart rate variability indicating sympathetic and parasympathetic activity
inflammatory cytokine profile in ulcerative colitis patients and healthy controls1 dayblood sample, Granulocyte-colony stimulating factor (G-CSF)
microbiota profile in ulcerative colitis patients and healthy controls1 dayfecal sample microbiota analysis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026